Table 3.
Grade 3/4 toxicities reported for SN-38 ADCs & irinotecan.
Irinotecan monotherapy | Labetuzumab govitecan | Sacituzumab govitecan | |
---|---|---|---|
Dosing regimen | once weekly 125 mg/m2 | Once weekly 10 mg/kg or twice weekly 6 mg/kg | days 1 and 8 of 21 day cycle 10 mg/kg |
Neutropenia | 26% | 10% | 24% |
Febrile neutropenia | 3% | 6% | |
Diarrhea | 31% | 2% | 3% |
Leukopenia | 28% | 2% | |
Anemia | 7% | 3% | 6% |